Peptides

Peptides with Neurotrophic Properties: Promising Therapeutics for Amyotrophic Lateral Sclerosis and Alzheimer’s Disease.

Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS) are two of the more common neurodegenerative diseases, with nearly seven million people in the US living with the conditions in 2023. While AD is more prevalent than ALS, they are both characterized by the progressive loss of specific neurons and glial cells in the central nervous…

Pentosan Polysulfate Sodium and its Effect for Improving Dyslipidemia and Osteoarthritis Knee Pain

Osteoarthritis (OA) is a progressive joint disease that occurs as a result of the cartilage that cushions the bones wearing down over time. Currently, it is estimated that over 500 million people worldwide are affected by OA.   Clinical OA studies have shown that when the condition is linked to metabolic syndrome, OA often results in…

Five Health Benefits of Peptide Therapy

Are you interested in regenerative medical treatments? Regenerative medicine, including stem cell treatments and peptide therapy, is growing in popularity with each passing year. Here we will discuss the benefits of Peptide Therapy! Peptide therapy is an innovative way to address everything from hair loss to sexual dysfunction. Peptides are molecules that form by combining amino…

Peptide BPC-157 Demonstrates Healing Effects on End-Stage Kidney Disease

End-stage kidney disease (ESKD) occurs when the kidneys cannot function at a level that supports the body’s needs. The kidneys serve a critical role in the body, removing waste and excess water.  Patients with chronic kidney disease may find the functionality of their kidneys declines slowly over ten to twenty years before reaching this stage.…

What is ARA-290 Peptide and How Can It Help?

The supplement and health industries are ever-evolving. Due to the constantly changing supplement landscape, it can be difficult to sort out genuine products from fads that do not offer any real value to consumers. This article will help you better understand peptides and especially the ARA-290 peptide. Recently, peptides have become a part of the…

Assessing the Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy

Sarcoidosis is a condition characterized by the presence of tiny clusters of inflammatory cells in various parts of the body.  Although most commonly observed in the lungs or lymph nodes, sarcoidosis can also affect other organs in the body, including the eyes, skin, and heart[1]. One of the most common clinical manifestations associated with sarcoidosis…

Using SS-31 (Elamipretide) to Improve Mitochondria Dysfunction and Impairment

Mitochondria are essential components of each cell in the human body. Responsible for generating the energy required for cells to complete their normal and required functions, large scale or systematic mitochondrial dysfunction, when left untreated often results in low energy, cell damage, and eventually cell death. Mitochondrial disease is most often observed in the heart,…

Targeting The Innate Repair Receptor To Treat Neuropathy Using ARA 290 Peptide

While medical knowledge and understanding of the pathophysiology associated with neuropathic pain have increased dramatically over the last 10 years, the medical community is still finding it difficult to control the chronic pain associated with this condition. Characterized by a wide range of clinical symptoms, including spontaneous pain, allodynia, and hyperalgesia, patients experiencing neuropathic pain…

Exploring Thymosin β4 as a Restorative/Regenerative Treatment Option for Neurological Injury and Neurodegenerative Diseases

Oligodendrocytes are key neural cells responsible for producing myelin sheaths that wrap around neuronal axons in the central nervous system[1]. Considering that thymosin β4’s (Tβ4) ability to promote neurological recovery in a range of neurological diseases has been well established, Chopp & Zhang (2015) propose oligodendrogenesis as the common link by which Tβ4 supports and…

Weighing the Potential Benefits of Thymosin Beta 4 Treatment (Tβ4) For Addressing Traumatic Brain Injury

With nearly 1.5 million traumatic brain injuries (TBI)  occurring each year in the United States and over 69 million more cases of TBI[1] occurring worldwide, TBI continues to be one of the leading annual causes of mortality and morbidity. Carrying with it an annual estimated cost exceeding  $56 billion, there has yet to be a…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.